# Harry W. Herr

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/harry-w-herr/

## Facts

| Field | Value |
| --- | --- |
| Citations | 42,045 |
| Field | Bladder and Urothelial Cancer Treatments |
| h-index | 106 |
| i10-index | 401 |
| Last Known Institution | Memorial Sloan Kettering Cancer Center |
| OpenAlex ID | https://openalex.org/A5111687196 |
| Works | 711 |

## Researcher papers

- [Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology](https://scholariq.org/papers/bladder-cancer-version-1-2026-nccn-clinical-practice-guidelines-in-oncology/)
- [Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial](https://scholariq.org/papers/comparing-open-radical-cystectomy-and-robot-assisted-laparoscopic-radical/)
- [CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma](https://scholariq.org/papers/cd8-tumor-infiltrating-lymphocytes-are-predictive-of-survival-in-muscle-invasive/)
- [Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review](https://scholariq.org/papers/critical-analysis-of-bladder-sparing-with-trimodal-therapy-in-muscle-invasive/)
- [NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022](https://scholariq.org/papers/nccn-guidelines-insights-bladder-cancer-version-2-2022/)
- [Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/bladder-cancer-version-5-2017-nccn-clinical-practice-guidelines-in-oncology/)
- [Bladder Cancer, Version 3.2024](https://scholariq.org/papers/bladder-cancer-version-3-2024/)
- [EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†](https://scholariq.org/papers/eau-esmo-consensus-statements-on-the-management-of-advanced-and-variant-bladder/)

## Researcher topics

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Urinary and Genital Oncology Studies](https://scholariq.org/topics/urinary-and-genital-oncology-studies-2/)
- [Urological Disorders and Treatments](https://scholariq.org/topics/urological-disorders-and-treatments-2/)
- [Urinary Tract Infections Management](https://scholariq.org/topics/urinary-tract-infections-management-2/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Researcher university

- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.